Amway (Malaysia) Holdings Bhd (6351) fair value: what the stock is really worth
As of Nov 10, 2026: fair value (intrinsic value) of Amway (Malaysia) Holdings Bhd stock MYR 4.62, price MYR 3.98, upside +16.1%, quality 67 out of 100. Rating: undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 3.54 MYR – 6.48 MYR · fair‑value band 4.13 MYR – 5.95 MYR · the 3.98 MYR price screens below the 4.62 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Amway (Malaysia) Holdings Bhd in your weekly email
Every Wednesday you see whether Amway (Malaysia) Holdings Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Amway (Malaysia) Holdings Berhad, an investment holding company, distributes consumer products in Malaysia. The company offers health, beauty, personal care, energy, children, personal shoppers, home living, and home care products.
Show moreShow less
It offres products under NUTRILITE, body key, XS, ARTISTRY, G&H, GLISTER, SANITIQUE, e-spring, ATMOSPHERE, and Amway home brands through physical and online stores. Amway (Malaysia) Holdings Berhad was founded in 1976 and is headquartered in Petaling Jaya, Malaysia.
Amway (Malaysia) Holdings Berhad operates as a subsidiary of GDA B.V.
Stock analysis
Amway (Malaysia) Holdings Bhd (6351) currently trades at 3.98 MYR, while our model-based Fair Value estimate is 4.62 MYR, implying the stock looks roughly 14% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 6.09 MYR per share, and 18 of the 24 models we run sit above the 3.98 MYR price.
Bear case: the Asset-Based group reads lowest at 0.8200 MYR, and 6 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: 4.13 MYR (bear) to 5.95 MYR (bull), the price of 3.98 MYR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Consumer Cyclical sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Amway (Malaysia) Holdings Bhd reported revenue of 1.1B MYR in FY2025 versus 1.5B MYR in FY2021, a compound −6.7%/yr. Reported net income was 45.3M MYR in FY2025, compounding +5.3%/yr from FY2021.
Key figures
Market cap 654M MYR (≈ $162M) Micro · P/E ratio 14.7 · P/S ratio 0.60 · EPS (TTM) 0.2700 MYR · Dividend yield 5.0% · Net margin 4.0% · Return on equity 18.2% · Return on assets (EBIT) 18.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −10% fair-value upside, at 16%, 6351 screens cheaper than that median.
Fair Value models
Bear4.13 MYRFair Value 4.62 MYRBull5.95 MYR
Price 3.98 MYR · Upside +16.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.0602 MYR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.5%
Start year 2020 (pandemic). Over 10 years: +1.0% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+4.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−0.7%
Dividend (yield on the price)5.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−0.7% vs −2.8%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 6%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−3.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about −5.7% a year for the price.
Compare Amway (Malaysia) Holdings Bhd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Retail · 215 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score67 · Top 25%
Fair Value upside+15.8% · Above median
Profitability
Return on equity (12 months)18.2% · Top 25%
Return on assets9.0% · Top 25%
Net margin (12 months)4.0% · Above median
Operating margin (12 months)4.1% · Below median
Growth and dividend
Revenue growth (quarter YoY)1.9% · Below median
Dividend yield (12 months)5.0% · Top 25%
Valuation Multiplesvs Specialty Retail median · lower = cheaper
P/E (12 months)14.7× · Cheaper than median
P/B2.57× · Pricier than median
P/S (12 months)0.60× · Cheaper than median
Price / free cash flow (fiscal year)10.6× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Amway (Malaysia) Holdings Bhd Fair Value". https://www.fairvalue-calculator.com/stock/6351
Frequently asked questions
Is Amway (Malaysia) Holdings Bhd (6351) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 4.62 MYR versus a price of 3.98 MYR, about +16% upside (undervalued).
What is the fair value of 6351?
Our model-based fair value for Amway (Malaysia) Holdings Bhd is 4.62 MYR (as of Nov 8, 2026), built from audited fundamentals. The current price: 3.98 MYR.
What is the quality score of 6351?
Amway (Malaysia) Holdings Bhd has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Amway (Malaysia) Holdings Bhd (6351)?
Our model-based price target is the fair value of 4.62 MYR (as of Nov 8, 2026) from 24 valuation models. Cautious scenario 4.13 MYR, optimistic scenario 5.95 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Amway (Malaysia) Holdings Bhd stock forecast for 2026?
Our models put fair value at 4.62 MYR, about +16% upside versus a price of 3.98 MYR (undervalued). Cautious scenario 4.13 MYR, optimistic scenario 5.95 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Amway (Malaysia) Holdings Bhd (6351)?
Amway (Malaysia) Holdings Bhd reported trailing-twelve-month revenue of about 1.1B MYR (latest available figure, as of Nov 8, 2026).
Does Amway (Malaysia) Holdings Bhd pay a dividend?
Amway (Malaysia) Holdings Bhd currently shows a dividend yield of 5.03% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Amway (Malaysia) Holdings Bhd (6351) and when is the ex-dividend date?
Amway (Malaysia) Holdings Bhd pays a dividend of 0.2 MYR per share a year, a dividend yield of 5.0%. The last ex-dividend date was Sep 7, 2026. A dividend has been paid every year since at least 2000. The payout ratio is 74.1% of earnings. Free cash flow covers the dividend 1.88 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Amway (Malaysia) Holdings Bhd (6351)?
For today's price to be fair in a discounted-cash-flow model, Amway (Malaysia) Holdings Bhd would have to grow free cash flow by -3.8 % per year for five years (discount rate 12.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.5 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 6351 use?
Our models discount Amway (Malaysia) Holdings Bhd at 12.6 %: a base by market capitalisation (micro), damped by beta 0.15, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Amway (Malaysia) Holdings Bhd that is -3.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.6 %) and the same formula as our fair value.
How much growth has Amway (Malaysia) Holdings Bhd (6351) delivered so far?
Over the past 5 years revenue at Amway (Malaysia) Holdings Bhd grew -0.5 % a year. The price currently implies free-cash-flow growth of -3.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Amway (Malaysia) Holdings Bhd (6351) growing?
The median revenue growth in the sector is +4.4 % a year. That is the yardstick for the growth priced into Amway (Malaysia) Holdings Bhd (-3.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Amway (Malaysia) Holdings Bhd (6351)?
The free-cash-flow yield on the price is 9.43 %: that much free cash flow Amway (Malaysia) Holdings Bhd produces per unit of market value. When it exceeds the discount rate of our models (12.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Amway (Malaysia) Holdings Bhd (6351)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Amway (Malaysia) Holdings Bhd it is 4.62 MYR per share (as of Nov 8, 2026), against a price of 3.98 MYR. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Amway (Malaysia) Holdings Bhd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 6351 trades below its calculated fair value: price 3.98 MYR, fair value 4.62 MYR, a gap of about +16% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6351?
No. The price is what the market pays today (3.98 MYR); the fair value is what the company's own numbers justify (4.62 MYR). For Amway (Malaysia) Holdings Bhd the two are 0.6400 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Amway (Malaysia) Holdings Bhd worth?
The market values Amway (Malaysia) Holdings Bhd at about 654M MYR (market capitalisation, as of Nov 8, 2026). Per share that is 3.98 MYR; our models calculate a fair value of 4.62 MYR per share.
What do the bullish and bearish scenarios say about 6351?
Our models span a range for Amway (Malaysia) Holdings Bhd: cautious scenario 4.13 MYR, base 4.62 MYR, optimistic 5.95 MYR per share (as of Nov 8, 2026, price 3.98 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6351?
Amway (Malaysia) Holdings Bhd trades at a price-to-earnings ratio of 14.7 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 4.62 MYR is built from several models across several years. Other multiples: P/B 2.6, P/S 0.6, EV/EBITDA 7.6.
How solid is the balance sheet of Amway (Malaysia) Holdings Bhd (6351)?
Balance-sheet figures for Amway (Malaysia) Holdings Bhd (as of Nov 8, 2026): return on equity 18.2%. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 6351 from its 52-week high?
Amway (Malaysia) Holdings Bhd trades at 3.98 MYR, about 22% below its 52-week high of 5.12 MYR and 1% above the low of 3.93 MYR (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of 4.62 MYR is for.
Which stocks are comparable to Amway (Malaysia) Holdings Bhd?
From the same area (Consumer Cyclical) we also value Alimentation Couche-Tard Inc, Williams-Sonoma, Inc, Ulta Beauty, Inc, Casey's General Stores, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Amway (Malaysia) Holdings Bhd stock attractive at the current price?
The data as of Nov 8, 2026: price 3.98 MYR, calculated fair value 4.62 MYR (+16%), Quality Score 67/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6351 calculated?
We run Amway (Malaysia) Holdings Bhd through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 4.62 MYR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. Amway (Malaysia) Holdings Bhd currently trades 14% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Amway (Malaysia) Holdings Bhd (6351)?
The closing price on Nov 10, 2026 was 3.98 MYR. Our model-based fair value is 4.62 MYR, about +16% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Amway (Malaysia) Holdings Bhd right now?
The price is below even our cautious bear case (4.13 MYR). The market is more pessimistic than our downside scenario. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Amway (Malaysia) Holdings Bhd
How large is the market capitalisation of Amway (Malaysia) Holdings Bhd (6351)?
The market capitalisation of Amway (Malaysia) Holdings Bhd is 654M MYR (≈ $162M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Amway (Malaysia) Holdings Bhd (6351)?
The price-to-sales ratio of Amway (Malaysia) Holdings Bhd is 0.60 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Amway (Malaysia) Holdings Bhd (6351)?
Earnings per share at Amway (Malaysia) Holdings Bhd are 0.2700 MYR (price ÷ EPS = P/E 14.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Amway (Malaysia) Holdings Bhd (6351)?
The dividend yield of Amway (Malaysia) Holdings Bhd is 5.0% (payout 74.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Amway (Malaysia) Holdings Bhd (6351)?
The net margin of Amway (Malaysia) Holdings Bhd is 4.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Amway (Malaysia) Holdings Bhd (6351)?
The return on equity (ROE) of Amway (Malaysia) Holdings Bhd is 18.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Amway (Malaysia) Holdings Bhd (6351)?
On an EBIT basis the return on assets of Amway (Malaysia) Holdings Bhd is 18.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Amway (Malaysia) Holdings Bhd (6351)?
The operating margin of Amway (Malaysia) Holdings Bhd is 4.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Amway (Malaysia) Holdings Bhd (6351)?
Revenue at Amway (Malaysia) Holdings Bhd is growing +1.9% versus a year earlier (3y avg −9.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Amway (Malaysia) Holdings Bhd (6351)?
Earnings per share at Amway (Malaysia) Holdings Bhd are growing +258% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Amway (Malaysia) Holdings Bhd in the live analysis
One click puts Amway (Malaysia) Holdings Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026